Concepedia

Fable Zustovich

FZ

43

Publications

1.2K

Citations

21

H-Index

2007

Active since

Affiliations

Istituto Oncologico Veneto(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Fondazione IRCCS Istituto Nazionale dei Tumori

University of Padua

Fable Zustovich is an author at Istituto Oncologico Veneto specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2007–2024

43

Publications

43

Sequential use of sorafenib and sunitinib in advanced renal‐cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases

Camillo Porta, Giuseppe Procopio, Giacomo Cartenì et al. · British Journal of Urology · 2011 · 87 citations

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study

Orazio Caffo, Ugo De Giorgi, Lucia Fratino et al. · European Urology · 2014 · 83 citations · Full text

, , +9

Sorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II study.

Fable Zustovich, Lorenza Landi, Giuseppe Lombardi et al. · PubMed · 2013 · 69 citations

A validated prognostic classifier for BRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study

Fotios Loupakis, Rossana Intini, Chiara Cremolini et al. · European Journal of Cancer · 2019 · 69 citations · Full text

, , +7

Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma

Giuseppe Lombardi, Fable Zustovich, Fabio Farinati et al. · Cancer · 2010 · 62 citations

Rows per page

1–5 of 43